Join our on-demand webinar and
discover innovations in the evolution of the
BD Libertas™ Wearable Injector*
Join our on-demand webinar and
Biotherapeutics are increasingly being considered for self-administration1
Intravenous administration of biotherapeutics contributes to the pressure on healthcare systems with the potential to be painful and inconvenient for patients
Subcutaneous administration has been shown to be a safe and effective dosing alternative to intravenous administration
Devices that allow self-administration help in shifting care to the home setting
Join our expert Rebecca Levin, Clinical and Human Factors Specialist, BD Medical – Pharmaceutical Systems to get a greater understanding of usability considerations to develop an effective and safe wearable drug delivery system for the treatment of chronic conditions in clinical and new care settings.
Webinar overview
Track the evolution of BD Libertas™ Wearable Injector in response to feedback from users and experts
Highlight usability considerations including simplified usage steps, dose delivery monitoring, and adhesive pad design
Future implications for development of safe and effective wearable injectors for clinical and new care settings
Get insights from our research and
explore our future roadmap for enhanced usability
Areas of focus
Simplified usage
steps
Dose delivery
progression
Adhesive pad
design
Instructional
graphics evolution
Don’t miss this chance to stay informed about the
newest advancements in the BD Libertas™ Wearable Injector*
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Habitant morbi tristique senectus et netus et malesuada fames. Bibendum est ultricies integer quis auctor elit sed.
- Lorem ipsum dolor sit amet,
- consectetur adipiscing elit, sed do eiusmod
- Habitant morbi tristique senectus et netus et
- Lorem ipsum dolor sit amet,
- consectetur adipiscing elit, sed do eiusmod
- Habitant morbi tristique senectus et netus et
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Habitant morbi tristique senectus et netus et malesuada fames. Bibendum est ultricies integer quis auctor elit sed.
- Lorem ipsum dolor sit amet,
- consectetur adipiscing elit, sed do eiusmod
- Habitant morbi tristique senectus et netus et
- Lorem ipsum dolor sit amet,
- consectetur adipiscing elit, sed do eiusmod
- Habitant morbi tristique senectus et netus et
Register below to join us and get valuable knowledge and expertise!
BD is committed to keeping your personal data protected and secure. More information on how we protect your personal data can be found in our privacy statement and our cookie policy.
*BD Libertas™ Wearable Injector is a product in development; some statements are forward looking and are subject to a variety of risks and uncertainties. BD Libertas™ Wearable Injector is a device component intended for drug-device combination products and not subject to FDA 510(k) clearance or separate EU CE mark certification.
1. Bittner B, Richter W, Schmidt J. Subcutaneous administration of biotherapeutics: An overview of current challenges and opportunities. BioDrugs. 2018;32(5):425-440. doi:10.1007/s40259-018-0295-0